Holen Sie sich die Stockscreener-App
20.35
1.45%
0.29
Schlusskurs vom Vortag:
$20.06
Offen:
$19.88
24-Stunden-Volumen:
164.67K
Relative Volume:
0.52
Marktkapitalisierung:
$840.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-136.98M
KGV:
-5.0622
EPS:
-4.02
Netto-Cashflow:
$-126.63M
1W Leistung:
-1.64%
1M Leistung:
+3.88%
6M Leistung:
-0.59%
1J Leistung:
-23.47%
1-Tages-Spanne:
$19.88
$20.60
1-Wochen-Bereich:
$19.88
$21.11
52-Wochen-Spanne:
$15.47
$30.41
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Firmenname
Arrivent Biopharma Inc
Sektor
Branche
Telefon
240-780-6356
Adresse
18 CAMPUS BLVD., NEWTOWN SQUARE
Vergleichen Sie AVBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
20.35 | 828.10M | 0 | -136.98M | -126.63M | -4.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-03-20 | Eingeleitet | B. Riley Securities | Buy |
| 2025-03-10 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-02-20 | Eingeleitet | Citigroup | Buy |
| 2024-02-20 | Eingeleitet | Goldman | Buy |
| 2024-02-20 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Arrivent Biopharma Inc Aktie (AVBP) Neueste Nachrichten
Avoiding Lag: Real-Time Signals in (AVBP) Movement - news.stocktradersdaily.com
ArriVent Maps Ambitious 2026 Oncology Push as Firmonertinib Program Gains Steam - MSN
Is ArriVent BioPharma Inc. stock in correction or buying zoneCEO Change & Smart Money Movement Alerts - newser.com
Can ArriVent BioPharma Inc. stock outperform in 2025 bull marketEarnings Overview Summary & Momentum Based Trading Signals - newser.com
Best data tools to analyze ArriVent BioPharma Inc. stockJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com
How institutional ownership impacts ArriVent BioPharma Inc. stockWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Will ArriVent BioPharma Inc. stock gain from lower inflationWeekly Profit Recap & Reliable Volume Spike Trade Alerts - newser.com
How ArriVent BioPharma Inc. stock reacts to Fed rate cutsGap Down & High Yield Equity Trading Tips - newser.com
Can momentum traders help lift ArriVent BioPharma Inc.Portfolio Value Summary & AI Forecasted Stock Moves - newser.com
Published on: 2025-11-19 02:02:03 - newser.com
Is ArriVent BioPharma Inc. stock a defensive play in 20252025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Why Red River Bancshares, Inc. stock attracts strong analyst attention - newser.com
Evaluating ArriVent BioPharma Inc. with trendline analysisWeekly Risk Summary & Free Real-Time Market Sentiment Alerts - newser.com
Analyzing ArriVent BioPharma Inc. with risk reward ratio chartsJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Published on: 2025-11-15 15:01:05 - newser.com
Why ArriVent BioPharma Inc. stock is favored by pension fundsLong Setup & Accurate Entry/Exit Alerts - newser.com
Momentum divergence signals in ArriVent BioPharma Inc. chartWeekly Stock Recap & Real-Time Volume Analysis - newser.com
What is the fair value of ArriVent BioPharma Inc. stock now2025 Earnings Impact & Fast Gain Stock Tips - Fundação Cultural do Pará
What is HC Wainwright’s Forecast for AVBP FY2025 Earnings? - Defense World
We Think ArriVent BioPharma (NASDAQ:AVBP) Needs To Drive Business Growth Carefully - Yahoo Finance
Real time pattern detection on ArriVent BioPharma Inc. stockWeekly Trade Recap & Pattern Based Trade Signal System - newser.com
ArriVent BioPharma, Inc.: Strategic Advancements and Promising Developments Drive Buy Rating with $45 Price Target - TipRanks
ArriVent Biopharma : Corporate Presentation November 2025 - MarketScreener
ArriVent BioPharma’s Promising Trial Results and Strategic Developments Drive Buy Rating - TipRanks
Discipline and Rules-Based Execution in AVBP Response - news.stocktradersdaily.com
ArriVent BioPharma Reports Q3 2025 Financial Results - TipRanks
ArriVent BioPharma Reports Third Quarter 2025 Financial Results - The Globe and Mail
ArriVent BioPharma stock price target raised to $47 from $32 at Clear Street - Investing.com Canada
Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):